Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease - Wikidata - awgldk - TriplyDB

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

http://www.wikidata.org/entity/Q36615510

about

Tau PET imaging: present and future directions.An In Vivo (11)C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease.Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease The Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease.Longitudinal Alteration of Intrinsic Brain Activity in the Striatum in Mild Cognitive Impairment Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury.Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels In vivo PET imaging of neuroinflammation in Alzheimer's disease.Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer's Disease Clinical Phenotypes? A Clinico-Pathological Perspective.Astroglial Vesicular Trafficking in Neurodegenerative Diseases.Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer's Disease.Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration.Non-aggregated Aβ25-35 Upregulates Primary Astrocyte Proliferation In Vitro.The roles of inflammation and immune mechanisms in Alzheimer's disease.The emerging role of PET imaging in dementia.Mild Cognitive Impairment, Neurodegeneration, and Personalized Lifestyle Medicine Neuroglia: Functional Paralysis and Reactivity in Alzheimer's Disease and Other Neurodegenerative Pathologies.Stratification of astrocytes in healthy and diseased brain.The association of MPO gene promoter polymorphisms with Alzheimer's disease risk in Chinese Han population.Targeting Neuroinflammation to Treat Alzheimer's Disease.Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease.Involvement of Astrocytes in Alzheimer's Disease from a Neuroinflammatory and Oxidative Stress Perspective.Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.An in vivo 11C-PK PET study of microglia activation in Fatal Familial Insomnia.Brain monoamine oxidases in human parkinsonian disorders.Inflammatory changes in very early Alzheimer's disease: friend, foe, or don't know?Physiology of Astroglia.Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.Neuroprotective Effects and Mechanism of β-Asarone against Aβ1-42-Induced Injury in Astrocytes.Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.Deciphering the Astrocyte Reaction in Alzheimer's Disease.In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies - towards clinical translation.Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy.Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer's Disease

P2860

Q34680852-9088285F-02A1-4A89-9520-1E321F85EC44 Q36358771-49626887-EA64-4A47-8883-1F5D76AEB55F Q36364053-2B89A2CA-7B38-4D8E-B3D7-2CBFCABB2A74 Q36846582-FF63CA4D-4802-42FD-937C-4BF1B2392335 Q36887309-EA7246EE-B2AF-46E1-945C-3D3852AC314D Q37214693-B6A91D58-668F-4B5E-9F75-6A19025991AD Q37736746-724EF59B-AB23-444E-B4D8-5D75F542CFA5 Q37743591-856A5712-C482-4B35-B48A-2BBD7050524C Q38648373-3C6ECA9D-4C49-488D-B2F6-1CC15C75CC96 Q38779574-D2339B53-6C8B-417C-A7CE-C89E1CD4A31E Q38833716-0D4B7ACC-239E-4EF5-83E8-20422E1E197C Q38954394-C4A99D6A-74F0-4B88-B691-BCD1D37BA1E5 Q39023028-3F1ACDAB-6EC6-4891-A5A8-05C3202DA7CB Q39139268-1ED4D1FB-02C8-4AA9-BFAC-436EB73C70D5 Q42369878-68D34CDF-E5C6-4566-B5E7-9F255B85FA20 Q42656274-668EDC64-E4AD-4463-B5C3-957362605DB9 Q42701971-CDE9E6A2-58E6-4D04-A556-41CA458E1614 Q42737354-2BA053D2-BD8C-42F8-A230-6F165F5D36CB Q45303020-1A99A8FD-B2E9-44CC-A4D3-09BBC88811DE Q46321594-BD5C8E96-6DA3-43D4-93E8-C71C04AFBD60 Q47108729-89CFE312-4BFD-4FBA-A7B8-0C86B18E37F0 Q47188911-63A3CCBD-539D-428A-9B34-8F220FAC97C8 Q47235819-2223A55A-A0B8-4FFB-8B74-DA4701F06319 Q47370188-26A013D6-5D48-4362-B972-1C2147E8B0F4 Q47386724-C7E257DB-C3B6-4A97-8B63-B934115689BC Q47555639-F53B0671-7FC4-4673-984C-3FA8B57D6AEC Q48011170-6140B528-6F3D-4B1D-8A2C-9DEA8373ED3B Q48876527-A19CE6FF-9583-4D23-BDEA-DCA0348D3C98 Q49917383-CD90A893-E5CF-4075-B865-7D5CB180B244 Q51766183-8E72F706-F3AB-4509-AD9E-C2748455D468 Q55057923-987608C5-42B0-45C3-B3BE-16E9B31C84B3 Q55178076-F9C86220-DCE6-47E8-804A-E81949DBD84D Q55364689-8568D392-8917-496B-8D0F-428E934CDDE3 Q55380020-1A931B77-AA1A-4B18-9703-09E89EEE30E9 Q55494083-91A2042E-76F7-4B39-8CE2-BDA7BC2F5DBF Q57817388-0E403714-DB36-48D6-94A2-95719B73C413

P2860

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

http://www.wikidata.org/entity/Q36615510

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Diverging longitudinal changes ...... l dominant Alzheimer's disease

@ast

Diverging longitudinal changes ...... l dominant Alzheimer's disease

@en

type

label

Diverging longitudinal changes ...... l dominant Alzheimer's disease

@ast

Diverging longitudinal changes ...... l dominant Alzheimer's disease

@en

prefLabel

Diverging longitudinal changes ...... l dominant Alzheimer's disease

@ast

Diverging longitudinal changes ...... l dominant Alzheimer's disease

@en

P1433

Q36615510-F74C2A48-6C10-4808-8B0A-7C6B1A4AD86A

P1476

Q36615510-45BEDDE1-5242-4752-AD0D-4FAA0D29CFE7

P2093

Q36615510-2806B0C5-C76C-4899-ADC2-FCB49EA52AC4

Q36615510-3A023D04-6850-4C5A-BDFC-B2B2107C33D4

Q36615510-60EDA0F0-127F-4A6D-A95D-ABD188AE7701

Q36615510-6BCBB30C-8D8C-47CC-B45B-448871B1CFD0

Q36615510-CAAC80AE-1F99-48CB-AF9A-FC5790B6F723

P2860

Q36615510-005DA8E6-DBC9-4F63-A075-C78D90AB5CCD

Q36615510-04FD08AB-4EF8-43EA-BBCB-99DD45F78EEA

Q36615510-06691C7D-2E64-4DF9-8445-A1FE1B6ADBA7

Q36615510-0769B12C-2B61-4E96-AB9C-08C1F81916AC

Q36615510-0B3E0440-AA7F-4C41-BD7F-A1D91B843E63

Q36615510-106F66C8-D7A3-498D-A77F-DCDF1C69DD97

Q36615510-1BBC4B00-AA5B-455F-8D36-2552DE135900

Q36615510-1CDE3F03-215B-478D-B324-B7006914722B

Q36615510-1E425E37-4767-49E0-9883-912657E08B09

Q36615510-285DAE68-460D-4C80-A123-4236151E945F

P304

Q36615510-2F010641-BCFC-46F1-ABA3-4CCFF50BC52F

P31

Q36615510-622E5799-E3DC-4EC1-99E1-25131654BFFE

P356

Q36615510-405F41EB-FAA7-406B-BFCE-233D300BCBDD

P407

Q36615510-3ED5CDFE-A841-4597-8F6B-31106F933427

P433

Q36615510-387FCB2D-F498-47E9-A9DD-F451F42FB4C7

P478

Q36615510-16B7A520-5545-4A4F-90D8-D73316C4719E

P50

Q36615510-77620B28-807E-4869-AC83-22DF80FB9D55

Q36615510-7C42F764-105C-4C0E-BE0D-2974A27EFD3E

Q36615510-9ECD1318-B32A-4830-B2E4-6C16B8A793D0

Q36615510-AD2DCD8F-7242-4EF6-B259-63A5EA44B7C4

Q36615510-B48E1D7E-8B4E-41C1-B789-3ABBC5FB91F6

Q36615510-B93F7488-AC75-4304-9E77-242602291749

Q36615510-EAF43025-FDBA-4BE9-AF6B-A63726FA9B10

P577

Q36615510-1D5875D9-0A42-4138-831F-D73EC6F16337

P5875

Q36615510-85AB59BB-10D5-415B-8134-F8B74A69D008

P698

Q36615510-A5C52653-EFB6-42DC-A471-18560A5682FF

P921

Q36615510-E5A10352-18A4-408A-A51A-AE2B5248FF3F

P932

Q36615510-3A546E8E-B8C8-45B5-B403-E2F5569B7E8A

P356

P1433

P1476

Diverging longitudinal changes ...... l dominant Alzheimer's disease

@en

P2093

Anders Wall

http://www.w3.org/2001/XMLSchema#string

Karim Farid

http://www.w3.org/2001/XMLSchema#string

Laure Saint-Aubert

http://www.w3.org/2001/XMLSchema#string

Steinunn Thordardottir

http://www.w3.org/2001/XMLSchema#string

Stephen F Carter

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Neuroinflammation in Alzheimer's disease

The mystery and magic of glia: a perspective on their roles in health and disease

Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography

Alzheimer's disease: the amyloid cascade hypothesis

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

Mild cognitive impairment as a diagnostic entity

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

P304

922-936

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWV404

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 3

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

Michael Schöll

Konstantinos Chiotis

Elena Rodriguez-Vieitez

Bengt Långström

Agneta Nordberg

P577

2016-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292077781

http://www.w3.org/2001/XMLSchema#string

P698

26813969

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4766380

http://www.w3.org/2001/XMLSchema#string